Centessa Pharmaceuticals

NASDAQ: CNTA · Real-Time Price · USD
12.43
0.32 (2.64%)
At close: May 08, 2025, 3:59 PM
13.31
7.08%
Pre-market: May 09, 2025, 04:00 AM EDT

Centessa Pharmaceuticals Statistics

Share Statistics

Centessa Pharmaceuticals has 132.63M shares outstanding. The number of shares has increased by 32% in one year.

Shares Outstanding 132.63M
Shares Change (YoY) 32%
Shares Change (QoQ) 0.74%
Owned by Institutions (%) 99.99%
Shares Floating n/a
Failed to Deliver (FTD) Shares 886
FTD / Avg. Volume 0.09%

Short Selling Information

The latest short interest is 5.2M, so 3.9% of the outstanding shares have been sold short.

Short Interest 5.2M
Short % of Shares Out 3.9%
Short % of Float 4.61%
Short Ratio (days to cover) 4.11

Valuation Ratios

The PE ratio is -8.13 and the forward PE ratio is -7.32. Centessa Pharmaceuticals's PEG ratio is -0.26.

PE Ratio -8.13
Forward PE -7.32
PS Ratio 0
Forward PS 3.5
PB Ratio 4.78
P/FCF Ratio -13.49
PEG Ratio -0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Centessa Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.25, with a Debt / Equity ratio of 0.29.

Current Ratio 9.25
Quick Ratio 9.25
Debt / Equity 0.29
Debt / EBITDA -0.53
Debt / FCF -0.83
Interest Coverage 19.94

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-3,061,779.22
Employee Count 77
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 2.84M
Effective Tax Rate -1.22%

Stock Price Statistics

The stock price has increased by 30.16% in the last 52 weeks. The beta is 1.54, so Centessa Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.54
52-Week Price Change 30.16%
50-Day Moving Average 14.16
200-Day Moving Average 15.13
Relative Strength Index (RSI) 41.72
Average Volume (20 Days) 1,010,962

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -201.06M
Net Income -235.76M
EBITDA -221.97M
EBIT -222.92M
Earnings Per Share (EPS) -2.06
Full Income Statement

Balance Sheet

The company has 383.22M in cash and 117.23M in debt, giving a net cash position of 266M.

Cash & Cash Equivalents 383.22M
Total Debt 117.23M
Net Cash 266M
Retained Earnings -988.7M
Total Assets 576.8M
Working Capital 478.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -142.06M and capital expenditures -34K, giving a free cash flow of -142.09M.

Operating Cash Flow -142.06M
Capital Expenditures -34K
Free Cash Flow -142.09M
FCF Per Share -1.24
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CNTA is $29, which is 133.3% higher than the current price. The consensus rating is "Buy".

Price Target $29
Price Target Difference 133.3%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Scores

Altman Z-Score 3.51
Piotroski F-Score 2